Business Description
Neola Medical AB
ISIN : SE0014829255
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.92 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 41.1 | |||||
3-Year EPS without NRI Growth Rate | 37.8 | |||||
3-Year FCF Growth Rate | 26.9 | |||||
3-Year Book Growth Rate | -15.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.45 | |||||
9-Day RSI | 51.54 | |||||
14-Day RSI | 52.24 | |||||
6-1 Month Momentum % | 45.45 | |||||
12-1 Month Momentum % | 8.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7 | |||||
Quick Ratio | 7 | |||||
Cash Ratio | 3.5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -76.7 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -13.4 | |||||
ROA % | -12.1 | |||||
ROIC % | -20.99 | |||||
ROC (Joel Greenblatt) % | -5342.4 | |||||
ROCE % | -13.95 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.77 | |||||
Price-to-Tangible-Book | 3.85 | |||||
EV-to-EBIT | -10.92 | |||||
EV-to-EBITDA | -13.09 | |||||
EV-to-FCF | -18.58 | |||||
Price-to-Net-Current-Asset-Value | 3.92 | |||||
Price-to-Net-Cash | 9.52 | |||||
Earnings Yield (Greenblatt) % | -9.16 | |||||
FCF Yield % | -4.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return %
Total Annual Return %
Neola Medical AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -0.18 | ||
Beta | 0 | ||
Volatility % | 63.75 | ||
14-Day RSI | 52.24 | ||
14-Day ATR (kr) | 0.103063 | ||
20-Day SMA (kr) | 1.978 | ||
12-1 Month Momentum % | 8.47 | ||
52-Week Range (kr) | 1.155 - 2.8 | ||
Shares Outstanding (Mil) | 70.15 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Neola Medical AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Neola Medical AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Neola Medical AB Frequently Asked Questions
What is Neola Medical AB(OSTO:NEOLA)'s stock price today?
When is next earnings date of Neola Medical AB(OSTO:NEOLA)?
Does Neola Medical AB(OSTO:NEOLA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |